The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Thyroid Eye Disease (TED) Market Change Between 2026 And 2030?

The thyroid eye disease (ted) market size has experienced robust expansion in recent years. Projections indicate it will expand from $2.29 billion in 2025 to $2.44 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 6.6%. This historical growth is primarily due to factors such as a rise in autoimmune thyroid disorder prevalence, enhanced clinical identification of ted symptoms, increased application of corticosteroid treatments, broader availability of ophthalmology services, and an increase in referrals from endocrinology clinics.

The thyroid eye disease (TED) market is anticipated to show significant expansion in the coming years, with its valuation expected to reach $3.12 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.3%. This projected growth during the forecast period stems from factors such as the increasing uptake of novel biologics like teprotumumab, a surge in investments for autoimmune disease research, the wider availability of minimally invasive surgical procedures, a heightened emphasis on quality-of-life outcomes for patients, and a rising demand for personalized TED treatments. Furthermore, prominent trends for this forecast span include the wider adoption of targeted biologic therapies, an increase in the use of combination treatment strategies, a greater focus on early disease intervention, the expansion of specialized ophthalmic care services, and the refinement of patient-centered treatment models.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

What Are The Main Drivers Accelerating The Growth Of The Thyroid Eye Disease (TED) Market?

The expansion of the Thyroid Eye Disease (TED) market is anticipated to be driven by the increasing prevalence of thyroid disorders. These disorders are medical conditions affecting the thyroid gland’s function, leading to hormonal imbalances seen in conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease itself. The rise in thyroid disorders stems from factors like increased iodine intake, autoimmune conditions, genetic predisposition, and improved diagnostic rates due to greater awareness. Thyroid Eye Disease (TED) itself contributes to the growing number of thyroid disorder cases, being a common and serious complication of Graves’ disease, which heightens the overall burden and recognition of thyroid-related conditions. For instance, in May 2024, the Canadian Cancer Society, a Canada-based non-profit organization, projected that in 2024, Canada is expected to have an estimated 6,600 new cases of thyroid cancer diagnosed, with approximately 280 fatalities. Consequently, the increasing incidence of thyroid disorders is fueling the growth of the Thyroid Eye Disease (TED) market.

How Is Segment Classification Applied In The Thyroid Eye Disease (TED) Market?

The thyroid eye disease (ted) market covered in this report is segmented –

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Other Drug Types

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery

What Trends Are Affecting The Growth Of The Thyroid Eye Disease (TED) Market?

Key companies operating in the thyroid cancer diagnostic market are developing innovative solutions, such as the RNA sequencing test, to enhance the accuracy of cancer fusion detection across numerous solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that enables the analysis of the quantity and sequence of RNA in a sample, providing insights into gene expression and the overall transcriptome. For instance, in May 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be particularly useful in identifying fusions in cancers like non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

Which Industry Players Are Present In The Thyroid Eye Disease (TED) Market?

Major companies operating in the thyroid eye disease (ted) market are Viridian Therapeutics Inc, Tourmaline Bio Inc, Sling Therapeutics Inc, Immunovant Inc, Hoffmann‑La Roche AG, H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Sanofi SA, Alexion Pharmaceuticals Inc, Septerna Corporation

Access The Complete Thyroid Eye Disease (TED) Market Report:

https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

Which Region Contributes The Most To The Thyroid Eye Disease (TED) Market?

North America was the largest region in the thyroid eye disease (TED) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (ted) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Thyroid Eye Disease (TED) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp

Browse Through More Reports Similar to the Global Thyroid Eye Disease (TED) Market 2026, By The Business Research Company

Eye Melanoma Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report

Thyroid Function Test Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-function-test-global-market-report

Thyroid Cancer Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.